On April 30, 2026, the FDA formally proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list entirely - the regulatory mechanism that governs which active pharmaceutical ingredients outsourcing facilities may use
Visit our Fullscript supplements store to set up an account and start shopping
Biotech Peptides offers a wide catalog of USA-made research peptides and is an established name among independent researchers
These are similar whatever the version and related to levels of the drugs in the blood rather than how they are administered, said Dr Mark Porter in The Times
As Allure previously reported, one popular workaround is labeling restricted or banned peptides as for research only, then selling them online
53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice